Comps need to pull up. Maybe- with acquisition of BD, this metric will be satisfied?
We took employees from IIIlumina- maybe- paybacks a -#$%$br />
collaboration with Illumina to evaluate the potential of integrating TrovaGene's urine-based nucleic acid technology with Illumina's gene sequencing technology can be a game changer going forward
What price do you put on a cure for diseases?
While- I can't encourage you to email the guy or make a phone call- if you like the returns on the stock, then continue to be the blind squirrel looking for his nuts.
linked in 22/221/239
Best post ever on this board. Thank-you for a realistic approach to intellectual property and requirements of market/sales potential vs chronic comments from Rosie_O, viewing through her glasses, x-spouse.